title: Long-term infliximab treatment for refractory type III juvenile pityriasis rubra pilaris.
authors.forename: Clio
authors.initials: C
authors.lastname: Dessinioti
authors.forename: Theognosia
authors.initials: T
authors.lastname: Vergou
authors.forename: Evaggelia
authors.initials: E
authors.lastname: Moustou
authors.forename: Andreas
authors.initials: A
authors.lastname: Katsambas
authors.forename: Christina
authors.initials: C
authors.lastname: Antoniou
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D010916:Pityriasis Rubra Pilaris / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab